BerghJNorbergTSjogrenSLindgrenAHolmbergL. Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nat Med1995; 1: 1029–34.
2.
AasTBorresenALGeislerSSmith-SorensenBJohnsenHVarhaugJESpecific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nat Med1996; 2: 811–4.
3.
SheffieldVCBeckJSKwitekAESandstromDWStoneEM. The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics1993; 16: 325–32.
4.
CondieAEelesRBorresenALColesCCooperCProsserJ. Detection of point mutations in the p53 gene: comparison of single-strand conformation polymorphism, constant denaturant gel electrophoresis, and hydroxylamine and osmium tetroxide techniques. Hum Mutat1993; 2: 58–66.
5.
LyamichevVBrowMADDahlbergJE. Structure-specific endonucleolytic cleavage of nucleic acids by eubacterial DNA polymerases. Science1993; 260: 778–83.
6.
HsuICTokiwaTBennettWMetcalfRAWelshJASunTp53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines. Carcinogenesis1993; 14: 987–92.